Given the challenges and delays of COVID-19, this latest annual report has been provided in an abbreviated format, providing an overview of
current trends with respect to the diagnosis, care and outcomes of men with prostate cancer.

The clinical data included was collected from men diagnosed in the 5-year period between 2015, when PCOR-ANZ commenced operations as a
bi-national registry, and 2019. It also includes PROMs data from those men, which was collected 12 months post treatment; or 12 months post
diagnosis if commencing active surveillance/ watchful waiting (AS/WW).

In this brief report, we have chosen to focus on bi-national comparisons between Australia and New Zealand. We hope clinicians, researchers
and consumers alike will find it a useful guide to understanding ongoing trends.

Finally, we would like to acknowledge our debt of gratitude to the 382 participating clinicians, 250 participating hospitals and all of our dedicated
PCOR-ANZ staff and committee members whose continued efforts make this report possible, especially under the challenging circumstances we are currently facing. But in particular, it is the men with prostate cancer who gave their time to complete PROMs questionnaires that we wish to thank. It is only your willingness to share your data that allows us to continue to help improve outcomes and standards of care for men
diagnosed with prostate cancer.